|
LOC550643 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.05755420981768E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.22457599616155E-13 |
| Normal-vs-Stage2 |
5.52370038597871E-10 |
| Normal-vs-Stage3 |
2.442800E-04 |
| Normal-vs-Stage4 |
1.180050E-04 |
| Stage1-vs-Stage2 |
3.302800E-01 |
| Stage1-vs-Stage3 |
9.793400E-01 |
| Stage1-vs-Stage4 |
7.426200E-02 |
| Stage2-vs-Stage3 |
5.273600E-01 |
| Stage2-vs-Stage4 |
3.616400E-02 |
| Stage3-vs-Stage4 |
3.323600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0467629247587E-13 |
| Normal-vs-AfricanAmerican |
5.600000E-04 |
| Normal-vs-Asian |
1.163810E-04 |
| Caucasian-vs-AfricanAmerican |
2.614000E-01 |
| Caucasian-vs-Asian |
6.207200E-01 |
| AfricanAmerican-vs-Asian |
2.987600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.2007955154163E-11 |
| Normal-vs-Female |
6.28508356470547E-12 |
| Male-vs-Female |
7.592800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.704200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.18830000178849E-08 |
| Normal-vs-Age(61-80Yrs) |
2.00861549615183E-12 |
| Normal-vs-Age(81-100Yrs) |
1.239130E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.389800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.469800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.172400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.430400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.198800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.012200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.908260E-02 |
| Normal-vs-Grade 2 |
2.17603712826531E-14 |
| Normal-vs-Grade 3 |
5.32570000322252E-08 |
| Normal-vs-Grade 4 |
5.775300E-04 |
| Grade 1-vs-Grade 2 |
1.646770E-01 |
| Grade 1-vs-Grade 3 |
1.943760E-01 |
| Grade 1-vs-Grade 4 |
7.538200E-01 |
| Grade 2-vs-Grade 3 |
9.322400E-01 |
| Grade 2-vs-Grade 4 |
1.537990E-01 |
| Grade 3-vs-Grade 4 |
2.647800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62458935193399E-12 |
| Normal-vs-ccB subtype |
2.657700E-03 |
| ccA subtype-vs-ccB subtype |
9.383500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66570000015298E-08 |
| Normal-vs-N1 |
7.59800000000865E-05 |
| N0-vs-N1 |
8.232200E-01 |
|
|
